{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:05:33Z","timestamp":1793232333862,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hawaii has one of the highest incidences of Campylobacteriosis in the United States, but there remains little published data on circulating strains or antimicrobial resistance. We characterized 110 clinical <jats:italic>Campylobacter<\/jats:italic> isolates (106\u2009C. <jats:italic>jejuni<\/jats:italic>, 4\u2009<jats:italic>C<\/jats:italic>. <jats:italic>coli<\/jats:italic>) processed at Tripler Army Medical Center in Honolulu, HI from 2012\u20132016. Twenty-five percent of <jats:italic>C<\/jats:italic>. <jats:italic>jejuni<\/jats:italic> isolates exhibited fluoroquinolone (FQ) resistance, compared with 16% for tetracycline (TET), and 0% for macrolides. Two of the four <jats:italic>C<\/jats:italic>. <jats:italic>coli<\/jats:italic> isolates were resistant to FQ, TET, and macrolides. <jats:italic>C<\/jats:italic>. <jats:italic>jejuni<\/jats:italic> isolates further underwent multilocus sequence typing, pulsed-field gel electrophoresis, and molecular capsular typing. Nineteen capsule types were observed, with two capsule types (HS2 and HS9) being associated with FQ resistance (p\u2009&lt;\u20090.001 and p\u2009=\u20090.006, respectively). HS2 FQ-resistant isolates associated with clonal complex 21, possibly indicating clonal spread in FQ resistance. Macrolides should be considered for treatment of suspect cases due to lack of observed resistance.<\/jats:p>","DOI":"10.1038\/s41598-018-29461-z","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T09:35:01Z","timestamp":1533029701000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Antibiotic resistance, molecular characterizations, and clinical manifestations of Campylobacteriosis at a military medical center in Hawaii from 2012\u20132016: a retrospective analysis"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1384-9973","authenticated-orcid":false,"given":"Evan C.","family":"Ewers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K.","family":"Anisowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas M.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Seronello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"Barnhill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Lustik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Willie","family":"Agee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Washington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md A.","family":"Nahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladaporn","family":"Bodhidatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apichai","family":"Srijan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supaporn","family":"Rukasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patcharawalai","family":"Wassanarungroj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirigade","family":"Ruekit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panida","family":"Nobthai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett E.","family":"Swierczewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woradee","family":"Lurchachaiwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oralak","family":"Serichantalergs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viseth","family":"Ngauy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,6]]},"reference":[{"key":"29461_CR1","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1086\/319760","volume":"32","author":"BM Allos","year":"2001","unstructured":"Allos, B. M. Campylobacter jejuni Infections: update on emerging issues and trends. Clin Infect Dis 32, 1201\u20131206, https:\/\/doi.org\/10.1086\/319760 (2001).","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"29461_CR2","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1086\/513783","volume":"176","author":"BM Allos","year":"1997","unstructured":"Allos, B. M. Association between Campylobacter infection and Guillain-Barre syndrome. J Infect Dis 176(Suppl 2), S125\u2013128 (1997).","journal-title":"J Infect Dis"},{"key":"29461_CR3","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1093\/infdis\/153.3.552","volume":"153","author":"MJ Blaser","year":"1986","unstructured":"Blaser, M. J. et al. Extraintestinal Campylobacter jejuni and Campylobacter coli infections: host factors and strain characteristics. J Infect Dis 153, 552\u2013559 (1986).","journal-title":"J Infect Dis"},{"key":"29461_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.idc.2017.01.002","volume":"31","author":"SK Schmitt","year":"2017","unstructured":"Schmitt, S. K. Reactive Arthritis. Infectious disease clinics of North America 31, 265\u2013277, https:\/\/doi.org\/10.1016\/j.idc.2017.01.002 (2017).","journal-title":"Infectious disease clinics of North America"},{"key":"29461_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-14-1203","volume":"14","author":"J Keithlin","year":"2014","unstructured":"Keithlin, J., Sargeant, J., Thomas, M. K. & Fazil, A. Systematic review and meta-analysis of the proportion of Campylobacter cases that develop chronic sequelae. BMC public health 14, 1203, https:\/\/doi.org\/10.1186\/1471-2458-14-1203 (2014).","journal-title":"BMC public health"},{"key":"29461_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.15585\/mmwr.mm6615a1","volume":"66","author":"EP Marder","year":"2017","unstructured":"Marder, E. P. et al. Incidence and Trends of Infections with Pathogens Transmitted Commonly Through Food and the Effect of Increasing Use of Culture-Independent Diagnostic Tests on Surveillance - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2013\u20132016. MMWR Morb Mortal Wkly Rep 66, 397\u2013403, https:\/\/doi.org\/10.15585\/mmwr.mm6615a1 (2017).","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"29461_CR7","unstructured":"Health, H. S. D. o. Historical Summary of Reported Notifiable Diseases in Hawaii 1990\u20132016 (2017)."},{"key":"29461_CR8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/0035-9203(83)90122-0","volume":"77","author":"FD Pien","year":"1983","unstructured":"Pien, F. D., Hsu, A. K., Padua, S. A., Isaacson, N. S. & Naka, S. Campylobacter jejuni enteritis in Honolulu, Hawaii. Trans R Soc Trop Med Hyg 77, 492\u2013494 (1983).","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"29461_CR9","first-page":"495","volume":"64","author":"SM Crim","year":"2015","unstructured":"Crim, S. M. et al. Preliminary incidence and trends of infection with pathogens transmitted commonly through food - Foodborne Diseases Active Surveillance Network, 10 U.S. sites, 2006\u20132014. MMWR Morb Mortal Wkly Rep 64, 495\u2013499 (2015).","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"29461_CR10","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1086\/319292","volume":"183","author":"P Effler","year":"2001","unstructured":"Effler, P. et al. Sporadic Campylobacter jejuni infections in Hawaii: associations with prior antibiotic use and commercially prepared chicken. J Infect Dis 183, 1152\u20131155, https:\/\/doi.org\/10.1086\/319292 (2001).","journal-title":"J Infect Dis"},{"key":"29461_CR11","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1016\/j.watres.2011.03.033","volume":"45","author":"EJ Viau","year":"2011","unstructured":"Viau, E. J. et al. Bacterial pathogens in Hawaiian coastal streams\u2013associations with fecal indicators, land cover, and water quality. Water Res 45, 3279\u20133290, https:\/\/doi.org\/10.1016\/j.watres.2011.03.033 (2011).","journal-title":"Water Res"},{"key":"29461_CR12","unstructured":"Antimicrobial Resistance Biggest Threats, https:\/\/www.cdc.gov\/drugresistance\/biggest_threats.html (2016)."},{"key":"29461_CR13","unstructured":"Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics, http:\/\/www.who.int\/medicines\/publications\/global-priority-list-antibiotic-resistant-bacteria\/en\/ (2017)."},{"key":"29461_CR14","unstructured":"CDC. National Antimicrobial Monitoring System for Enteric Bacteria (NARMS): Human Isolates Surveillance Report for 2014 (Final Report). (Atlanta, Georgia, 2016)."},{"key":"29461_CR15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3109\/00365548.2011.652163","volume":"44","author":"FQ Hou","year":"2012","unstructured":"Hou, F. Q., Sun, X. T. & Wang, G. Q. Clinical manifestations of Campylobacter jejuni infection in adolescents and adults, and change in antibiotic resistance of the pathogen over the past 16 years. Scand J Infect Dis 44, 439\u2013443, https:\/\/doi.org\/10.3109\/00365548.2011.652163 (2012).","journal-title":"Scand J Infect Dis"},{"key":"29461_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s40794-017-0056-y","volume":"3","author":"CJ Mason","year":"2017","unstructured":"Mason, C. J. et al. Antibiotic resistance in Campylobacter and other diarrheal pathogens isolated from US military personnel deployed to Thailand in 2002\u20132004: a case\u2013control study. Tropical Diseases, Travel Medicine and Vaccines 3, 13, https:\/\/doi.org\/10.1186\/s40794-017-0056-y (2017).","journal-title":"Tropical Diseases, Travel Medicine and Vaccines"},{"key":"29461_CR17","doi-asserted-by":"publisher","unstructured":"Post, A. et al. Antibiotic susceptibility profiles among Campylobacter isolates obtained from international travelers between 2007 and 2014. Eur J Clin Microbiol Infect Dis, https:\/\/doi.org\/10.1007\/s10096-017-3032-6 (2017).","DOI":"10.1007\/s10096-017-3032-6"},{"key":"29461_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1757-4749-2-15","volume":"2","author":"O Serichantalergs","year":"2010","unstructured":"Serichantalergs, O. et al. PFGE, Lior serotype, and antimicrobial resistance patterns among Campylobacter jejuni isolated from travelers and US military personnel with acute diarrhea in Thailand, 1998\u20132003. Gut Pathog 2, 15, https:\/\/doi.org\/10.1186\/1757-4749-2-15 (2010).","journal-title":"Gut Pathog"},{"key":"29461_CR19","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1708-8305.2008.00236.x","volume":"15","author":"ER Vlieghe","year":"2008","unstructured":"Vlieghe, E. R., Jacobs, J. A., Van Esbroeck, M., Koole, O. & Van Gompel, A. Trends of norfloxacin and erythromycin resistance of Campylobacter jejuni\/Campylobacter coli isolates recovered from international travelers, 1994 to 2006. J Travel Med 15, 419\u2013425, https:\/\/doi.org\/10.1111\/j.1708-8305.2008.00236.x (2008).","journal-title":"J Travel Med"},{"key":"29461_CR20","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1093\/jtm\/tax060","volume":"24","author":"MS Riddle","year":"2017","unstructured":"Riddle, M. S. et al. Guidelines for the prevention and treatment of travelers\u2019 diarrhea: a graded expert panel report. J Travel Med 24, S57\u2013s74, https:\/\/doi.org\/10.1093\/jtm\/tax026 (2017).","journal-title":"J Travel Med"},{"key":"29461_CR21","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1016\/j.vaccine.2016.02.080","volume":"34","author":"MS Riddle","year":"2016","unstructured":"Riddle, M. S. & Guerry, P. Status of vaccine research and development for Campylobacter jejuni. Vaccine 34, 2903\u20132906, https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.080 (2016).","journal-title":"Vaccine"},{"key":"29461_CR22","doi-asserted-by":"publisher","first-page":"e67375","DOI":"10.1371\/journal.pone.0067375","volume":"8","author":"BL Pike","year":"2013","unstructured":"Pike, B. L., Guerry, P. & Poly, F. Global Distribution of Campylobacter jejuni Penner Serotypes: A Systematic Review. PLoS One 8, e67375, https:\/\/doi.org\/10.1371\/journal.pone.0067375 (2013).","journal-title":"PLoS One"},{"key":"29461_CR23","unstructured":"Jorgensen, J. H., Pfaller, M. A., Carroll, K. C. & American Society for Microbiology. Manual of clinical microbiology. 11th edition. edn, (ASM Press, 2015)."},{"key":"29461_CR24","first-page":"2","volume":"30","author":"CLS Institute","year":"2010","unstructured":"Institute, C. L. S. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Approved Guideline-Second Edition. CLSI Document M45-A2 30, 2 (2010).","journal-title":"CLSI Document M45-A2"},{"key":"29461_CR25","first-page":"3","volume":"36","author":"CaLS Institute","year":"2016","unstructured":"Institute, Ca. L. S. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-fifth informational supplement. CLSI Document M100-S25 36, 3 (2016).","journal-title":"CLSI Document M100-S25"},{"key":"29461_CR26","doi-asserted-by":"publisher","first-page":"e0144349","DOI":"10.1371\/journal.pone.0144349","volume":"10","author":"F Poly","year":"2015","unstructured":"Poly, F. et al. Updated Campylobacter jejuni Capsule PCR Multiplex Typing System and Its Application to Clinical Isolates from South and Southeast Asia. PLoS One 10, e0144349, https:\/\/doi.org\/10.1371\/journal.pone.0144349 (2015).","journal-title":"PLoS One"},{"key":"29461_CR27","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1128\/JCM.02348-10","volume":"49","author":"F Poly","year":"2011","unstructured":"Poly, F. et al. Discrimination of major capsular types of Campylobacter jejuni by multiplex PCR. J Clin Microbiol 49, 1750\u20131757, https:\/\/doi.org\/10.1128\/JCM.02348-10 (2011).","journal-title":"J Clin Microbiol"},{"key":"29461_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1128\/JCM.39.1.14-23.2001","volume":"39","author":"KE Dingle","year":"2001","unstructured":"Dingle, K. E. et al. Multilocus sequence typing system for Campylobacter jejuni. J Clin Microbiol 39, 14\u201323, https:\/\/doi.org\/10.1128\/JCM.39.1.14-23.2001 (2001).","journal-title":"J Clin Microbiol"},{"key":"29461_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-595","volume":"11","author":"KA Jolley","year":"2010","unstructured":"Jolley, K. A. & Maiden, M. C. BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics 11, 595, https:\/\/doi.org\/10.1186\/1471-2105-11-595 (2010).","journal-title":"BMC Bioinformatics"},{"key":"29461_CR30","unstructured":"Prevention, C. f. D. C. a. Standard Operating Procedure for PulseNet PFGE of Campylobacter jejuni (2013)."},{"key":"29461_CR31","doi-asserted-by":"publisher","first-page":"360","DOI":"10.7326\/0003-4819-98-3-360","volume":"98","author":"MJ Blaser","year":"1983","unstructured":"Blaser, M. J., Wells, J. G., Feldman, R. A., Pollard, R. A. & Allen, J. R. Campylobacter enteritis in the United States. A multicenter study. Ann Intern Med 98, 360\u2013365 (1983).","journal-title":"Ann Intern Med"},{"issue":"852","key":"29461_CR32","doi-asserted-by":"publisher","first-page":"e851","DOI":"10.1016\/j.cmi.2015.05.031","volume":"21","author":"AP Heikema","year":"2015","unstructured":"Heikema, A. P. et al. Campylobacter jejuni capsular genotypes are related to Guillain-Barre syndrome. Clin Microbiol Infect 21(852), e851\u2013859, https:\/\/doi.org\/10.1016\/j.cmi.2015.05.031 (2015).","journal-title":"Clin Microbiol Infect"},{"key":"29461_CR33","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/jam.13419","volume":"122","author":"S Pergola","year":"2017","unstructured":"Pergola, S. et al. Genetic diversity and antimicrobial resistance profiles of Campylobacter coli and Campylobacter jejuni isolated from broiler chicken in farms and at time of slaughter in central Italy. Journal of applied microbiology 122, 1348\u20131356, https:\/\/doi.org\/10.1111\/jam.13419 (2017).","journal-title":"Journal of applied microbiology"},{"key":"29461_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00584-z","volume":"7","author":"Y Tang","year":"2017","unstructured":"Tang, Y. et al. Rising fluoroquinolone resistance in Campylobacter isolated from feedlot cattle in the United States. Scientific reports 7, 494, https:\/\/doi.org\/10.1038\/s41598-017-00584-z (2017).","journal-title":"Scientific reports"},{"key":"29461_CR35","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1017\/S0950268813003245","volume":"142","author":"J Kovac","year":"2014","unstructured":"Kovac, J. et al. The evidence for clonal spreading of quinolone resistance with a particular clonal complex of Campylobacter jejuni. Epidemiology and infection 142, 2595\u20132603, https:\/\/doi.org\/10.1017\/s0950268813003245 (2014).","journal-title":"Epidemiology and infection"},{"key":"29461_CR36","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3389\/fmicb.2015.01169","volume":"6","author":"J Kovac","year":"2015","unstructured":"Kovac, J. et al. High genetic similarity of ciprofloxacin-resistant Campylobacter jejuni in centralEurope. Frontiers in microbiology 6, 1169, https:\/\/doi.org\/10.3389\/fmicb.2015.01169 (2015).","journal-title":"Frontiers in microbiology"},{"key":"29461_CR37","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.4161\/hv.27985","volume":"10","author":"AC Maue","year":"2014","unstructured":"Maue, A. C., Poly, F. & Guerry, P. A capsule conjugate vaccine approach to prevent diarrheal disease caused by Campylobacter jejuni. Hum Vaccin Immunother 10, 1499\u20131504, https:\/\/doi.org\/10.4161\/hv.27985 (2014).","journal-title":"Hum Vaccin Immunother"},{"key":"29461_CR38","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1128\/IAI.01056-08","volume":"77","author":"MA Monteiro","year":"2009","unstructured":"Monteiro, M. A. et al. Capsule polysaccharide conjugate vaccine against diarrheal disease caused by Campylobacter jejuni. Infect Immun 77, 1128\u20131136, https:\/\/doi.org\/10.1128\/iai.01056-08 (2009).","journal-title":"Infect Immun"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29461-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29461-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29461-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T08:21:28Z","timestamp":1671610888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29461-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,6]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["29461"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-29461-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,6]]},"assertion":[{"value":"4 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11736"}}